Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Efficacy of Venetoclax Combined With Azacitidine Induction Therapy of Early T-cell Precursor-like Acute Lymphoblastic Leukemia and T-ALL With Myeloid Mutations

NCT07012447 is registered in ClinicalTrials.gov with yuejun Liu as lead sponsor.

NCT NCT07012447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07012447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Efficacy of Venetoclax Combined With Azacitidine Induction Therapy of Early T-cell Precursor-like Acute Lymphoblastic Leukemia and T-ALL With Myeloid Mutations
Lead sponsor
yuejun Liu
Phase
Phase 2
Overall status
Recruiting
Start date
April 1, 2025
Completion date
May 1, 2028
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early t acute lymphoblastic leukemia, mixed phenotype acute leukemia, t/myeloid, nos, t-acute lymphoblastic leukemia